Platelets and tissue factor

Platelets

Volumn 16, Issue 6, 2005, Pages 313-319

  Losche W ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

Cell cell interaction; Coagulation; Microvesicles; Monocytes; Platelets; Tissue factor

Indexed keywords

THROMBOPLASTIN;

BLOOD CLOTTING; CELL INTERACTION; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; LEUKOCYTE; MONOCYTE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL; MONOCYTES; THROMBOPLASTIN;

EID: 27144446139     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.1080/09537100500140190     Document Type: Review

References (93)

1. Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thrombosis Research 1996;81:1-41.
2. Mann KG, van't VC, Cawthern K, Butenas S. The role of the tissue factor pathway in initiation of coagulation. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Trombosis 1998;9(Suppl 1):S3-S7.
3. Hatakeyama K, Asada Y, Marutsuka K, Sato Y, Kamikubo Y, Sumiyoshi A. Localization and activity of tissue factor in human aortic atherosclerotic lesions. Atherosclerosis 1997;133: 213-219.
4. Corti R, Badimon JJ. Biologic aspects of vulnerable plaque. Current Opinion in Cardiology 2002;17:616-625.
5. Viles-Gonzalez JF, Anand SX, Zafar MU, Fuster V, Badimon JJ. Tissue factor coagulation pathway: A new therapeutic target in atherothrombosis. Journal of Cardiovascular Pharmacology 2004;43:669-676.
6. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological roles. Blood Coagulation & Fibrinolysis: An international journal in haemostasis and trombosis 1998;9(Suppl 1):S9-14.
7. Osterud B, Rao LV, Olsen JO. Induction of tissue factor expression in whole blood: Lack of evidence for the presence of tissue factor expression in granulocytes. Thrombosis and Haemostasis 2000;83:861-867.
8. Erlich J, Fearns C, Mathison J, Ulevitch RJ, Mackman N. Lipopolysaccharide induction of tissue factor expression in rabbits. Infection and Immunity 1999;67:2540-2546.
9. Levi M, van der Poll T, ten Cate H, van Deventer JH. The cytokine-mediated imbalance between coagulant and anticoagulant mechanisms in sepsis and endotoxaemia. European Journal of Clinical Investigation 1997;27:3-9.
10. Semeraro N, Colucci M. Tissue factor in health and disease. Thrombosis Haemostasis 1997;78:759-764.
11. Albrecht S, Kotzsch M, Siegen G, Luther T, Grossmann H, Grosser M, Muller M. Detection of circulating tissue factor and factor VII in a normal population. Thrombosis and Haemostasis 1996;75:772-777.
12. Suefuji H, Ogawa H, Yasue H, Kaikita K, Soejima H, Motoyama T, Mizuno Y, Oshima S, Saito T, Tsuji I, Kumeda K, Kamikubo Y, Nakamura S. Increased plasma tissue factor levels in acute myocardial infarction. American Heart Journal 1997;134:253-259.
13. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. The Journal of Trauma 1999;47:719-723.
14. Soejima H, Ogawa H, Yasue H, Kaikita K, Nishiyama K, Misumi K, Takazoe K, Miyao Y, Yoshimura M, Kugiyama K, Nakamura S, Tsuji I, Kumeda K. Heightened tissue factor associated with tissue factor pathway inhibitor and prognosis in patients with unstable angina. Circulation 1999;99:2908-2913.
15. Aras O, Shet A, Bach RR, Hysjulien JL, Slungaard A, Hebbel RP, Escolar G, Jilma B, Key NS. Induction of microparticle- and cell-associated intravascular tissue factor in human endotoxemia. Blood 2004;103:4545-4553.
16. Vickers J, Russwurm S, Dohrn B, Spangenberg P, Reinhart K, Lösche W. Monocyte tissue factor (CD142) and Mac-1 (CD11b) are increased in septic patients. Thrombosis and Haemostasis 1998;79:1219-1220.
17. Berckmans RJ, Neiuwland R, Boing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thrombosis and Haemostasis 2001;85:639-646.
18. Biro E, Sturk-Maquelin KN, Vogel GM, Meuleman DG, Smit MJ, Hack CE, Sturk A, Nieuwland R. Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner. Journal of Thrombosis and Haemostasis 2003;1:2561-2568.
19. Diamant M, Tushuizen ME, Sturk A, Nieuwland R. Cellular microparticles: New players in the field of vascular disease? European Journal of Clinical Investigation 2004;34:392-401.
20. Giesen PL, Rauch U, Bohrmann B, Kling D, Roqu M, Fallen JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor: Another view of thrombosis. Proceedings of the National Academy of Sciences of the United States of America 1999;96:2311-2315.
21. Freyssinet JM. Cellular microparticles: What are they bad or good for? Journal of Thrombosis and Haemostasis 2003;1:1655-1662.
22. Hoffman M, Monroe DM, III. A cell-based model of hemostasis. Thrombosis and Haemostasis 2001;85:958-965.
23. Nemerson Y, Giesen PL. Some thoughts about localization and expression of tissue factor. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Trombosis 1998;9(Suppl 1):S45-47.
24. Roberts HR, Monroe DM, Oliver JA, Chang JY, Hoffman M. Newer concepts of blood coagulation. Haemophilia 1998; 4:331-334.
25. Bevers EM, Comfurius P, Dekkers DW, Harmsma M, Zwaal RF. Transmebrane phospholipid distribution in blood cells: Control mechanisms and pathophysiological significance. Biological Chemistry 1998;379:973-986.
26. Heemskerk JW, Siljander PR, Bevers EM, Farndale RW, Lindhout T. Receptors and signalling mechanisms in the procoagulant response of platelets. Platelets 2000;11: 301-306.
27. Niemetz J, Marcus AJ. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. Journal of Clinical Investigation 1974;54:1437-1443.
28. Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Seminars in Thrombosis and Haemostasis 2001;27:605-617.
29. Finder PB, Hunt JA, Zacharski LR. In vitro stimulation of monocyte tissue factor activity by autologous platelets. American Journal of Hematology 1985;19:317-325.
30. Engstad CS, Lia K, Rekdal O, Olsen JO, Osterud B. A novel biological effect of platelet factor 4 (PF4): Enhancement of LPS-induced tissue factor activity in monocytes. Journal of Leukocyte Biology 1995;58:575-581.
31. Halvorsen H, Olsen JO, Osterud B. Granulocytes enhance LPS-induced tissue factor activity in monocytes via an interaction with platelets. Journal of Leukocyte Biology 1993;54:275-282.
32. Osterud B. The high responder phenomenon: Enhancement of LPS induced tissue factor activity in monocytes by platelets and granulocytes. Platelets 1995;6:119-125.
33. Bevers EM, Comfurius P, Zwaal RF. Platelet procoagulant activity: Physiological significance and mechanisms of exposure. Blood Reviews 1991;5:146-154.
34. Solum NO. Procoagulant expression in platelets and defects leading to clinical disorders. Arteriosclerosis, Thrombosis and Vascular Biology 1999;19:2841-2846.
35. Bach R. Tissue factor de-encryption. Journal of Thrombosis and Haemostasis 2003;1(Suppl 1):SY17.
36. Key NS, Bach RR. Tissue factor as a therapeutic target. Thrombosis and Haemostasis 2001;85:375-376.
37. Osterud B. The role of platelets in decrypting monocyte tissue factor. Semininars in Hematology 2001;38:2-5.
38. Osterud B. The role of platelets in decrypting monocyte tissue factor. Disease-a-Month 2003;49:7-13.
39. Satta N, Toti F, Feugeas O, Bohbot A, Dachary-Prigent J, Eschwege V, Hedman H, Freyssinet JM. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. Journal of Immunology 1994;153:3245-3255.
40. Oberle V, Setzer F, Fischer A, Claus R, Lösche W. Interaction between platelet derived vesicles and monocyte derived vesicles in whole blood. Hämostaseologie 2005;25:A34.
41. Celi A, Pellegrini G, Lorenzet R, De Blasi A, Ready N, Furie BC, Furie B. P-selectin induces the expression of tissue factor on monocytes. Proceedings of the National Academy of Sciences of the United States of America 1994;91:8767-8771.
42. Furie B, Furie BC. P-selectin induction of tissue factor biosynthesis and expression. Haemostasis 1996; 26(Suppl 1):60-65.
43. Lorenzet R, Napoleone E, Celi A, Pellegrini G, Di Santo A. Cell-cell interaction and tissue factor expression. Blood Coagulation & Fibrinolysis: An international journal in haemostasis and trombosis 1998;9(Suppl 1):S49-S59.
44. Navarro C, Furie BC, Furie B. Binding of the lectin-EGF domain of P-selectin to PSGL-1 on monocytes is required for upregulation of tissue factor and is independent of CD14. Blood 1996;88:653A.
45. Pellegrini G, Malandra R, Celi A, Furie BC, Furie B, Lorenzet R. 12-Hydroxyeicosatetraenoic acid upregulates P-selectin-induced tissue factor activity on monocytes. FEBS Letters 1998;441:463-466.
46. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood 1991;78:1730-1737.
47. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood 1991;78:1760-1769.
48. Amirkhosravi A, Alexander M, May K, Francis DA, Warnes G, Biggerstaff J, Francis JL. The importance of platelets in the expression of monocyte tissue factor antigen measured by a new whole blood flow cytometric assay. Thrombosis and Haemostasis 1996;75:87-95.
49. Lindmark E, Tenno T, Siegbahn A. Role of platelet P-selectin and CD40 ligand in the induction of monocytic tissue factor expression. Arteriosclerosis, Thrombosis and Vascular Biology 2000;20:2322-2328.
50. Schonbeck U, Mach F, Sukhova GK, Herman M, Graber P, Kehry MR, Libby P. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells. American Journal of Pathology 2000;156:7-14.
51. Slupsky JR, Kalbas M, Willuweit A, Henn V, Kroczek RA, Muller-Berghaus G. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40. Thrombosis and Haemostasis 1998;80:1008-1014.
52. Scholz T, Sanderson HM, Temmler U, Spangenberg P, Heptinstall S, Lösche W. Differences in monocyte tissue factor exposure induced by collagen-activated platelets or endotoxin. Platelets 2000;11:125.
53. Scholz T, Sanderson HM, Temmler U, Unbehaun A, Krause S, Heptinstall S, Lösche W. Transfer of tissue factor from platelets to monocytes. Annals of Hematology 2001;80(Suppl I):219.
54. Zillmann A, Luther T, Muller I, Kotzsch M, Spannagl M, Kauke T, Oelschlagel U, Zahler S, Engelmann B. Platelet-associated tissue factor contributes to the collagen-triggered activation of blood coagulation. Biochemical and Biophysical Research Communications 2001;281:603-609.
55. Camera M, Frigerio M, Toschi V, Brambilla M, Rossi F, Cottell DC, Maderna P, Parolari A, Bonzi R, De Vincenti O, Tremoli E. Platelet activation induces cell-surface immunoreactive tissue factor expression, which is modulated differently by antiplatelet drugs. Arteriosclerosis, Thrombosis and Vascular Biology 2003;23:1690-1696.
56. Müller I, Klocke A, Alex M, Kotzsch M, Luther T, Morgenstern E, Zieseniss S, Zahler S, Preissner K, Engelmann B. Intravascular tissue factor initiates coagulation via circulating microvesicles and platelets. The FASEB Journal 2003;17:476-478.
57. Perez-Pujol S, Lozano M, Aras O, Key N, White JG, McCullough J, Escolar G. Stored platelets contain residual amounts of tissue factor. Journal of Thrombosis and Haemostasis 2003;1(Suppl 1):P0068.
58. Siddiqui FA, Desai H, Amirkhosravi A, Amaya M, Francis JL. The presence and release of tissue factor from human platelets. Platelets 2002;13:247-253.
59. Camera M, Frigerio M, Marenzi GC, Salvioni A, Biglioli P, Tremoli E. Platelet-associated tissue factor expression in patients with unstable coronary artery disease. Journal of Thrombosis and Haemostasis 2003;1(Suppl 1):OC009.
60. Lösche W, Scholz T, Temmler U, Oberle V, Claus RA. Platelet-derived microvesicles transfer tissue factor to monocytes but not to neutrophils. Platelets 2004;15:109-116.
61. Scholz T, Temmler U, Krause S, Heptinstall S, Lösche W. Transfer of tissue factor from platelets to monocytes: Role of platelet-derived microvesicles and CD62P. Thrombosis and Haemostasis 2002;88:1033-1038.
62. Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: A circulating, soluble, thrombogenic protein. Nature Medicine 2003;9:458-462.
63. Zhao L, Bath PMW, May J, Lösche W, Heptinstall S. P-selectin, tissue factor and CD40 ligand expression on platelet-leucocyte conjugates in the presence of a GPIIb/IIIa antagonist. Platelets 2003;14:473-480.
64. Scholz T, Zhao L, Temmler U, Heptinstall S, Lösche W. The GPIIb/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro. Platelets 2002;13:401-406.
65. Zhao L, Bath P, Lösche W, Heptinstall S. Platelet-monocyte interaction and GPIIb/IIIa blockade. Thrombosis and Haemostasis 2004;92:888-890.
66. Zhao L, Bath P, Fox S, May J, Judge H, Lösche W, Heptinstall S. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current Medical Research and Opinion 2003;19:178-186.
67. Huang F, Hong E. Platelet glycoprotein IIb/IIIa inhibition and its clinical use. Current Medicinal Chemistry: Cardiovascular and Hematological Agents 2004;2:187-196.
68. Rossi ML, Zavalloni D. Inhibitors of platelets glycoprotein IIb/IIIa (GP IIb/IIIa) receptor: Rationale for their use in clinical cardiology. Mini Reviews in Medicinal Chemistry 2004;4:703-709.
69. Schneider DJ, Aggarwal A. Development of glycoprotein IIb-IIIa antagonists: Translation of pharmacodynamic effects into clinical benefit. Expert Review of Cardiovascular Therapy 2004;2:903-913.
70. Zhao L, Bath PM, Fox S, May J, Judge H, Losche W, Heptinstall S. The effects of GPIIb-IIIa antagonists and a combination of three other antiplatelet agents on platelet-leukocyte interactions. Current Medical Research and Opinion 2003;19:178-186.
71. Li N, Hu H, Lindqvist M, Wikstrom-Jonsson E, Goodall AH, Hjemdahl P. Platelet-leukocyte cross talk in whole blood. Arteriosclerosis, Thrombosis and Vascular Biology 2000;20:2702-2708.
72. Klinkhardt U, Graff J, Harder S. Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P-selectin expression in a human ex vivo in vitro model. Clinical Pharmacology and Therapeutics 2002;71:176-185.
73. Hu H, Varon D, Hjemdahl P, Savion N, Schulman S, Li N. Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins. Thrombosis and Haemostasis 2003;90:679-687.
74. Fredrickson BJ, Turner NA, Kleiman NS, Graziadei N, Maresh K, Mascelli MA, Effron MB, McIntire LV. Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty. Circulation 2000;101: 1122-1129.
75. Steiner S, Seidinger D, Huber K, Kaun C, Minar E, Kopp CW. Effect of glycoprotein IIb/IIIa antagonist abciximab on monocyte-platelet aggregates and tissue factor expression. Arteriosclerosis, Thrombosis and Vascular Biology 2003;23:1697-1702.
76. Neumann FJ, Zohlnhofer D, Fakhoury L, Ott I, Gawaz M, Schomig A. Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction. Journal of the American College of Cardiology 1999;34:1420-1426.
77. May AE, Neumann FJ, Gawaz M, Ott I, Walter H, Schomig A. Reduction of monocyte-platelet interaction and monocyte activation in patients receiving antiplatelet therapy after coronary stent implantation. European Heart Journal 1997;18:1913-1920.
78. Kopp CW, Steiner S, Nasel C, Seidinger D, Mlekusch I, Lang W, Bartok A, Ahmadi R, Minar E. Abciximab reduces monocyte tissue factor in carotid angioplasty and stenting. Stroke 2003;34:2560-2567.
79. Furman MI, Kereiakes DJ, Krueger LA, Mueller MN, Pieper K, Broderick TM, Schneider JF, Howard WL, Fox ML, Barnard MR, Frelinger AL III, Michelson AD. Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab. American Heart Journal 2001;142:790-798.
80. Chew DP, Bhatt DL, Sapp S, Topol EJ. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: A meta-analysis of phase III multicenter randomized trials. Circulation 2001;103:201-206.
81. Quinn MJ, Plow EF, Topol EJ. Platelet glycoprotein IIb/IIIa inhibitors: Recognition of a two-edged sword? Circulation 2002;106:379-385.
82. Engelmann B, Luther T, Muller I. Intravascular tissue factor pathway - A model for rapid initiation of coagulation within the blood vessel. Thrombosis and Haemostasis 2003;89:3-8.
83. Bugen P, Dugrillon A, Gunaydin A, Eichler H, Kluter H. Messenger RNA profiling of human platelets by microarray hybridization. Thrombosis and Haemostasis 2003;90:738-748.
84. Dugrillon A, Dobowolski C, Lösel R, Klüter H, Bugen P. Lack of protein biosynthesis in leukocyte-depleted platelet preparations. Platelets 2004;15:239-240.
85. McRedmond JP, Park SD, Reilly DF, Coppinger JA, Maguire PB, Shields DC, Fitzgerald DJ. Integration of proteomics and genomics in platelets: A profile of platelet proteins and platelet-specific genes. Molecular and Cellular Proteomics 2004;3:133-144.
86. Fink L, Holschermann H, Kwapiszewska G, Muyal JP, Lengemann B, Bohle RM, Santoso S. Characterization of platelet-specific mRNA by real-time PCR after laser-assisted microdissection. Thrombosis and Haemostasis 2003;90:749-756.
87. Rauch U, Bonderman D, Bohrmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood 2000;96:170-175.
88. Conde I, Shrimpton CN, Thiagarajan P, Lopez JA. Tissue factor-bearing microparticles arise from monocyte lipid rafts and can fuse with activated plarelets, consolidating all of the membrane-bound coagulation reactions on the platelet surface. Journal of Thrombosis and Haemostasis 2004;1(Suppl 1):OC146.
89. Balasubramanian V, Vele O, Nemerson Y. Local shear conditions and platelet aggregates regulate the incorporation and activity of circulating tissue factor in ex-vivo thrombi. Thrombosis and Haemostasis 2002;88:822-826.
90. Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: Real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002;100:2787-2792.
91. Falati S, Gross P, Merrill-Skoloff G, Furie BC, Furie B. Real-time in vivo imaging of platelets, tissue factor and fibrin during anerial thrombus formation in the mouse. Nature Medicine 2002;8:1175-1181.
92. Falati S, Liu Q, Gross P, Merrill-Skoloff G, Chou J, Vandendries E, Celi A, Croce K, Furie BC, Furie B. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. Journal of Experimental Medicine 2003;197:1585-1598.
93. Vandendries ER, Furie BC, Furie B. Role of P-selectin and PSGL-1 in coagulation and thrombosis. Thrombosis and Haemostasis 2004;92:459-466.